These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 18396333)

  • 21. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
    Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z
    Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifunctional nanoparticles of biodegradable copolymer blend for cancer diagnosis and treatment.
    Pan J; Liu Y; Feng SS
    Nanomedicine (Lond); 2010 Apr; 5(3):347-60. PubMed ID: 20394529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation of Docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy.
    Mi Y; Liu Y; Feng SS
    Biomaterials; 2011 Jun; 32(16):4058-66. PubMed ID: 21396707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
    Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L
    Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
    Sun B; Ranganathan B; Feng SS
    Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for breast cancer therapy.
    Huang L; Chen H; Zheng Y; Song X; Liu R; Liu K; Zeng X; Mei L
    Integr Biol (Camb); 2011 Oct; 3(10):993-1002. PubMed ID: 21938302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of poly(ε-caprolactone) chain lengths of poly(ε-caprolactone)-co-d-α-tocopheryl-poly(ethylene glycol) 1000 succinate nanoparticles for enhancement of quercetin delivery to SKBR3 breast cancer cells.
    Suksiriworapong J; Phoca K; Ngamsom S; Sripha K; Moongkarndi P; Junyaprasert VB
    Eur J Pharm Biopharm; 2016 Apr; 101():15-24. PubMed ID: 26802701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
    Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
    Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo investigation on PLA-TPGS nanoparticles for controlled and sustained small molecule chemotherapy.
    Zhang Z; Lee SH; Gan CW; Feng SS
    Pharm Res; 2008 Aug; 25(8):1925-35. PubMed ID: 18509603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol).
    Mu L; Feng SS
    J Control Release; 2002 Apr; 80(1-3):129-44. PubMed ID: 11943393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®.
    Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA
    J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
    Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
    Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
    Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ
    Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro investigation on poly(lactide)-Tween 80 copolymer nanoparticles fabricated by dialysis method for chemotherapy.
    Zhang Z; Feng SS
    Biomacromolecules; 2006 Apr; 7(4):1139-46. PubMed ID: 16602731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
    Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poly(L-lactide)-vitamin E TPGS nanoparticles enhanced the cytotoxicity of doxorubicin in drug-resistant MCF-7 breast cancer cells.
    Li PY; Lai PS; Hung WC; Syu WJ
    Biomacromolecules; 2010 Oct; 11(10):2576-82. PubMed ID: 20722436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery.
    Lee SH; Zhang Z; Feng SS
    Biomaterials; 2007 Apr; 28(11):2041-50. PubMed ID: 17250886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
    Gan CW; Feng SS
    Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticles of poly(D,L-lactide)/methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxel.
    Dong Y; Feng SS
    J Biomed Mater Res A; 2006 Jul; 78(1):12-9. PubMed ID: 16596586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.